The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Platinum-based Anticancer APIs Market Research Report 2025
Synopsis
The global Platinum-based Anticancer APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer APIs.
Report Scope
The Platinum-based Anticancer APIs market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum-based Anticancer APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum-based Anticancer APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum-based Anticancer APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Platinum-based Anticancer APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Platinum-based Anticancer APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Platinum-based Anticancer APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Platinum-based Anticancer APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum-based Anticancer APIs.
Report Scope
The Platinum-based Anticancer APIs market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum-based Anticancer APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum-based Anticancer APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Qilu Pharmaceutical
Neptunus
Hisun
Jiangsu HaiCi biological pharmaceutical
Kunming Guiyan Pharmaceutical
Lingnan Pharmacy
Jinzhou Jiutai Pharmaceutical
Nanjing Hairun Pharmaceutical
Simcere
Teva
Cipla
Heraeus
Hospira(Pfizer)
Taj Pharmaceuticals
Umicore Precious Metals Chemistry
Segment by Type
Cisplatin
Carboplatin
Oxaliplatin
Nedaplatin
Others
Segment by Application
Testicular Cancer
Osteosarcoma
Breast Cancer
Esophageal Cancer
NSCLC
Other
Production by Region
North America
Europe
China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Platinum-based Anticancer APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Platinum-based Anticancer APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Platinum-based Anticancer APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Platinum-based Anticancer APIs Market Overview
1.1 Product Definition
1.2 Platinum-based Anticancer APIs Segment by Type
1.2.1 Global Platinum-based Anticancer APIs Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Cisplatin
1.2.3 Carboplatin
1.2.4 Oxaliplatin
1.2.5 Nedaplatin
1.2.6 Others
1.3 Platinum-based Anticancer APIs Segment by Application
1.3.1 Global Platinum-based Anticancer APIs Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Testicular Cancer
1.3.3 Osteosarcoma
1.3.4 Breast Cancer
1.3.5 Esophageal Cancer
1.3.6 NSCLC
1.3.7 Other
1.4 Global Market Growth Prospects
1.4.1 Global Platinum-based Anticancer APIs Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Platinum-based Anticancer APIs Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Platinum-based Anticancer APIs Production Estimates and Forecasts (2019-2030)
1.4.4 Global Platinum-based Anticancer APIs Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Platinum-based Anticancer APIs Production Market Share by Manufacturers (2019-2024)
2.2 Global Platinum-based Anticancer APIs Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Platinum-based Anticancer APIs, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Platinum-based Anticancer APIs Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Platinum-based Anticancer APIs, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Platinum-based Anticancer APIs, Product Offered and Application
2.8 Global Key Manufacturers of Platinum-based Anticancer APIs, Date of Enter into This Industry
2.9 Platinum-based Anticancer APIs Market Competitive Situation and Trends
2.9.1 Platinum-based Anticancer APIs Market Concentration Rate
2.9.2 Global 5 and 10 Largest Platinum-based Anticancer APIs Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Platinum-based Anticancer APIs Production by Region
3.1 Global Platinum-based Anticancer APIs Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Platinum-based Anticancer APIs Production Value by Region (2019-2030)
3.2.1 Global Platinum-based Anticancer APIs Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Platinum-based Anticancer APIs by Region (2025-2030)
3.3 Global Platinum-based Anticancer APIs Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Platinum-based Anticancer APIs Production by Region (2019-2030)
3.4.1 Global Platinum-based Anticancer APIs Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Platinum-based Anticancer APIs by Region (2025-2030)
3.5 Global Platinum-based Anticancer APIs Market Price Analysis by Region (2019-2024)
3.6 Global Platinum-based Anticancer APIs Production and Value, Year-over-Year Growth
3.6.1 North America Platinum-based Anticancer APIs Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Platinum-based Anticancer APIs Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Platinum-based Anticancer APIs Production Value Estimates and Forecasts (2019-2030)
3.6.4 India Platinum-based Anticancer APIs Production Value Estimates and Forecasts (2019-2030)
4 Platinum-based Anticancer APIs Consumption by Region
4.1 Global Platinum-based Anticancer APIs Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Platinum-based Anticancer APIs Consumption by Region (2019-2030)
4.2.1 Global Platinum-based Anticancer APIs Consumption by Region (2019-2024)
4.2.2 Global Platinum-based Anticancer APIs Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Platinum-based Anticancer APIs Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Platinum-based Anticancer APIs Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Platinum-based Anticancer APIs Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Platinum-based Anticancer APIs Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Platinum-based Anticancer APIs Production by Type (2019-2030)
5.1.1 Global Platinum-based Anticancer APIs Production by Type (2019-2024)
5.1.2 Global Platinum-based Anticancer APIs Production by Type (2025-2030)
5.1.3 Global Platinum-based Anticancer APIs Production Market Share by Type (2019-2030)
5.2 Global Platinum-based Anticancer APIs Production Value by Type (2019-2030)
5.2.1 Global Platinum-based Anticancer APIs Production Value by Type (2019-2024)
5.2.2 Global Platinum-based Anticancer APIs Production Value by Type (2025-2030)
5.2.3 Global Platinum-based Anticancer APIs Production Value Market Share by Type (2019-2030)
5.3 Global Platinum-based Anticancer APIs Price by Type (2019-2030)
6 Segment by Application
6.1 Global Platinum-based Anticancer APIs Production by Application (2019-2030)
6.1.1 Global Platinum-based Anticancer APIs Production by Application (2019-2024)
6.1.2 Global Platinum-based Anticancer APIs Production by Application (2025-2030)
6.1.3 Global Platinum-based Anticancer APIs Production Market Share by Application (2019-2030)
6.2 Global Platinum-based Anticancer APIs Production Value by Application (2019-2030)
6.2.1 Global Platinum-based Anticancer APIs Production Value by Application (2019-2024)
6.2.2 Global Platinum-based Anticancer APIs Production Value by Application (2025-2030)
6.2.3 Global Platinum-based Anticancer APIs Production Value Market Share by Application (2019-2030)
6.3 Global Platinum-based Anticancer APIs Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Jiangsu Hengrui Medicine
7.1.1 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information
7.1.2 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Product Portfolio
7.1.3 Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Jiangsu Hengrui Medicine Main Business and Markets Served
7.1.5 Jiangsu Hengrui Medicine Recent Developments/Updates
7.2 Nanjing Pharmaceutical Factory
7.2.1 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information
7.2.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Product Portfolio
7.2.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Nanjing Pharmaceutical Factory Main Business and Markets Served
7.2.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
7.3 Qilu Pharmaceutical
7.3.1 Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information
7.3.2 Qilu Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
7.3.3 Qilu Pharmaceutical Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Qilu Pharmaceutical Main Business and Markets Served
7.3.5 Qilu Pharmaceutical Recent Developments/Updates
7.4 Neptunus
7.4.1 Neptunus Platinum-based Anticancer APIs Corporation Information
7.4.2 Neptunus Platinum-based Anticancer APIs Product Portfolio
7.4.3 Neptunus Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Neptunus Main Business and Markets Served
7.4.5 Neptunus Recent Developments/Updates
7.5 Hisun
7.5.1 Hisun Platinum-based Anticancer APIs Corporation Information
7.5.2 Hisun Platinum-based Anticancer APIs Product Portfolio
7.5.3 Hisun Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Hisun Main Business and Markets Served
7.5.5 Hisun Recent Developments/Updates
7.6 Jiangsu HaiCi biological pharmaceutical
7.6.1 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information
7.6.2 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Product Portfolio
7.6.3 Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served
7.6.5 Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
7.7 Kunming Guiyan Pharmaceutical
7.7.1 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information
7.7.2 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
7.7.3 Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Kunming Guiyan Pharmaceutical Main Business and Markets Served
7.7.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
7.8 Lingnan Pharmacy
7.8.1 Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information
7.8.2 Lingnan Pharmacy Platinum-based Anticancer APIs Product Portfolio
7.8.3 Lingnan Pharmacy Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Lingnan Pharmacy Main Business and Markets Served
7.7.5 Lingnan Pharmacy Recent Developments/Updates
7.9 Jinzhou Jiutai Pharmaceutical
7.9.1 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information
7.9.2 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
7.9.3 Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Jinzhou Jiutai Pharmaceutical Main Business and Markets Served
7.9.5 Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
7.10 Nanjing Hairun Pharmaceutical
7.10.1 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information
7.10.2 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Product Portfolio
7.10.3 Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Nanjing Hairun Pharmaceutical Main Business and Markets Served
7.10.5 Nanjing Hairun Pharmaceutical Recent Developments/Updates
7.11 Simcere
7.11.1 Simcere Platinum-based Anticancer APIs Corporation Information
7.11.2 Simcere Platinum-based Anticancer APIs Product Portfolio
7.11.3 Simcere Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Simcere Main Business and Markets Served
7.11.5 Simcere Recent Developments/Updates
7.12 Teva
7.12.1 Teva Platinum-based Anticancer APIs Corporation Information
7.12.2 Teva Platinum-based Anticancer APIs Product Portfolio
7.12.3 Teva Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Teva Main Business and Markets Served
7.12.5 Teva Recent Developments/Updates
7.13 Cipla
7.13.1 Cipla Platinum-based Anticancer APIs Corporation Information
7.13.2 Cipla Platinum-based Anticancer APIs Product Portfolio
7.13.3 Cipla Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Cipla Main Business and Markets Served
7.13.5 Cipla Recent Developments/Updates
7.14 Heraeus
7.14.1 Heraeus Platinum-based Anticancer APIs Corporation Information
7.14.2 Heraeus Platinum-based Anticancer APIs Product Portfolio
7.14.3 Heraeus Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Heraeus Main Business and Markets Served
7.14.5 Heraeus Recent Developments/Updates
7.15 Hospira(Pfizer)
7.15.1 Hospira(Pfizer) Platinum-based Anticancer APIs Corporation Information
7.15.2 Hospira(Pfizer) Platinum-based Anticancer APIs Product Portfolio
7.15.3 Hospira(Pfizer) Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Hospira(Pfizer) Main Business and Markets Served
7.15.5 Hospira(Pfizer) Recent Developments/Updates
7.16 Taj Pharmaceuticals
7.16.1 Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information
7.16.2 Taj Pharmaceuticals Platinum-based Anticancer APIs Product Portfolio
7.16.3 Taj Pharmaceuticals Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Taj Pharmaceuticals Main Business and Markets Served
7.16.5 Taj Pharmaceuticals Recent Developments/Updates
7.17 Umicore Precious Metals Chemistry
7.17.1 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information
7.17.2 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Product Portfolio
7.17.3 Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Umicore Precious Metals Chemistry Main Business and Markets Served
7.17.5 Umicore Precious Metals Chemistry Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Platinum-based Anticancer APIs Industry Chain Analysis
8.2 Platinum-based Anticancer APIs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Platinum-based Anticancer APIs Production Mode & Process
8.4 Platinum-based Anticancer APIs Sales and Marketing
8.4.1 Platinum-based Anticancer APIs Sales Channels
8.4.2 Platinum-based Anticancer APIs Distributors
8.5 Platinum-based Anticancer APIs Customers
9 Platinum-based Anticancer APIs Market Dynamics
9.1 Platinum-based Anticancer APIs Industry Trends
9.2 Platinum-based Anticancer APIs Market Drivers
9.3 Platinum-based Anticancer APIs Market Challenges
9.4 Platinum-based Anticancer APIs Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Platinum-based Anticancer APIs Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Platinum-based Anticancer APIs Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Platinum-based Anticancer APIs Production Capacity (Kiloton) by Manufacturers in 2023
Table 4. Global Platinum-based Anticancer APIs Production by Manufacturers (2019-2024) & (Kiloton)
Table 5. Global Platinum-based Anticancer APIs Production Market Share by Manufacturers (2019-2024)
Table 6. Global Platinum-based Anticancer APIs Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Platinum-based Anticancer APIs Production Value Share by Manufacturers (2019-2024)
Table 8. Global Platinum-based Anticancer APIs Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum-based Anticancer APIs as of 2023)
Table 10. Global Market Platinum-based Anticancer APIs Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Platinum-based Anticancer APIs Production Sites and Area Served
Table 12. Manufacturers Platinum-based Anticancer APIs Product Types
Table 13. Global Platinum-based Anticancer APIs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Platinum-based Anticancer APIs Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Platinum-based Anticancer APIs Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Platinum-based Anticancer APIs Production Value Market Share by Region (2019-2024)
Table 18. Global Platinum-based Anticancer APIs Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Platinum-based Anticancer APIs Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Platinum-based Anticancer APIs Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 21. Global Platinum-based Anticancer APIs Production (Kiloton) by Region (2019-2024)
Table 22. Global Platinum-based Anticancer APIs Production Market Share by Region (2019-2024)
Table 23. Global Platinum-based Anticancer APIs Production (Kiloton) Forecast by Region (2025-2030)
Table 24. Global Platinum-based Anticancer APIs Production Market Share Forecast by Region (2025-2030)
Table 25. Global Platinum-based Anticancer APIs Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Platinum-based Anticancer APIs Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Platinum-based Anticancer APIs Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 28. Global Platinum-based Anticancer APIs Consumption by Region (2019-2024) & (Kiloton)
Table 29. Global Platinum-based Anticancer APIs Consumption Market Share by Region (2019-2024)
Table 30. Global Platinum-based Anticancer APIs Forecasted Consumption by Region (2025-2030) & (Kiloton)
Table 31. Global Platinum-based Anticancer APIs Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 33. North America Platinum-based Anticancer APIs Consumption by Country (2019-2024) & (Kiloton)
Table 34. North America Platinum-based Anticancer APIs Consumption by Country (2025-2030) & (Kiloton)
Table 35. Europe Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 36. Europe Platinum-based Anticancer APIs Consumption by Country (2019-2024) & (Kiloton)
Table 37. Europe Platinum-based Anticancer APIs Consumption by Country (2025-2030) & (Kiloton)
Table 38. Asia Pacific Platinum-based Anticancer APIs Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 39. Asia Pacific Platinum-based Anticancer APIs Consumption by Region (2019-2024) & (Kiloton)
Table 40. Asia Pacific Platinum-based Anticancer APIs Consumption by Region (2025-2030) & (Kiloton)
Table 41. Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 42. Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption by Country (2019-2024) & (Kiloton)
Table 43. Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption by Country (2025-2030) & (Kiloton)
Table 44. Global Platinum-based Anticancer APIs Production (Kiloton) by Type (2019-2024)
Table 45. Global Platinum-based Anticancer APIs Production (Kiloton) by Type (2025-2030)
Table 46. Global Platinum-based Anticancer APIs Production Market Share by Type (2019-2024)
Table 47. Global Platinum-based Anticancer APIs Production Market Share by Type (2025-2030)
Table 48. Global Platinum-based Anticancer APIs Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Platinum-based Anticancer APIs Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Platinum-based Anticancer APIs Production Value Share by Type (2019-2024)
Table 51. Global Platinum-based Anticancer APIs Production Value Share by Type (2025-2030)
Table 52. Global Platinum-based Anticancer APIs Price (US$/Ton) by Type (2019-2024)
Table 53. Global Platinum-based Anticancer APIs Price (US$/Ton) by Type (2025-2030)
Table 54. Global Platinum-based Anticancer APIs Production (Kiloton) by Application (2019-2024)
Table 55. Global Platinum-based Anticancer APIs Production (Kiloton) by Application (2025-2030)
Table 56. Global Platinum-based Anticancer APIs Production Market Share by Application (2019-2024)
Table 57. Global Platinum-based Anticancer APIs Production Market Share by Application (2025-2030)
Table 58. Global Platinum-based Anticancer APIs Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Platinum-based Anticancer APIs Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Platinum-based Anticancer APIs Production Value Share by Application (2019-2024)
Table 61. Global Platinum-based Anticancer APIs Production Value Share by Application (2025-2030)
Table 62. Global Platinum-based Anticancer APIs Price (US$/Ton) by Application (2019-2024)
Table 63. Global Platinum-based Anticancer APIs Price (US$/Ton) by Application (2025-2030)
Table 64. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Corporation Information
Table 65. Jiangsu Hengrui Medicine Specification and Application
Table 66. Jiangsu Hengrui Medicine Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. Jiangsu Hengrui Medicine Main Business and Markets Served
Table 68. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 69. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Corporation Information
Table 70. Nanjing Pharmaceutical Factory Specification and Application
Table 71. Nanjing Pharmaceutical Factory Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Nanjing Pharmaceutical Factory Main Business and Markets Served
Table 73. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 74. Qilu Pharmaceutical Platinum-based Anticancer APIs Corporation Information
Table 75. Qilu Pharmaceutical Specification and Application
Table 76. Qilu Pharmaceutical Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Qilu Pharmaceutical Main Business and Markets Served
Table 78. Qilu Pharmaceutical Recent Developments/Updates
Table 79. Neptunus Platinum-based Anticancer APIs Corporation Information
Table 80. Neptunus Specification and Application
Table 81. Neptunus Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Neptunus Main Business and Markets Served
Table 83. Neptunus Recent Developments/Updates
Table 84. Hisun Platinum-based Anticancer APIs Corporation Information
Table 85. Hisun Specification and Application
Table 86. Hisun Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Hisun Main Business and Markets Served
Table 88. Hisun Recent Developments/Updates
Table 89. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Corporation Information
Table 90. Jiangsu HaiCi biological pharmaceutical Specification and Application
Table 91. Jiangsu HaiCi biological pharmaceutical Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Jiangsu HaiCi biological pharmaceutical Main Business and Markets Served
Table 93. Jiangsu HaiCi biological pharmaceutical Recent Developments/Updates
Table 94. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Corporation Information
Table 95. Kunming Guiyan Pharmaceutical Specification and Application
Table 96. Kunming Guiyan Pharmaceutical Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Kunming Guiyan Pharmaceutical Main Business and Markets Served
Table 98. Kunming Guiyan Pharmaceutical Recent Developments/Updates
Table 99. Lingnan Pharmacy Platinum-based Anticancer APIs Corporation Information
Table 100. Lingnan Pharmacy Specification and Application
Table 101. Lingnan Pharmacy Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Lingnan Pharmacy Main Business and Markets Served
Table 103. Lingnan Pharmacy Recent Developments/Updates
Table 104. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Corporation Information
Table 105. Jinzhou Jiutai Pharmaceutical Specification and Application
Table 106. Jinzhou Jiutai Pharmaceutical Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Jinzhou Jiutai Pharmaceutical Main Business and Markets Served
Table 108. Jinzhou Jiutai Pharmaceutical Recent Developments/Updates
Table 109. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Corporation Information
Table 110. Nanjing Hairun Pharmaceutical Specification and Application
Table 111. Nanjing Hairun Pharmaceutical Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Nanjing Hairun Pharmaceutical Main Business and Markets Served
Table 113. Nanjing Hairun Pharmaceutical Recent Developments/Updates
Table 114. Simcere Platinum-based Anticancer APIs Corporation Information
Table 115. Simcere Specification and Application
Table 116. Simcere Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Simcere Main Business and Markets Served
Table 118. Simcere Recent Developments/Updates
Table 119. Teva Platinum-based Anticancer APIs Corporation Information
Table 120. Teva Specification and Application
Table 121. Teva Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Teva Main Business and Markets Served
Table 123. Teva Recent Developments/Updates
Table 124. Cipla Platinum-based Anticancer APIs Corporation Information
Table 125. Cipla Specification and Application
Table 126. Cipla Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. Cipla Main Business and Markets Served
Table 128. Cipla Recent Developments/Updates
Table 129. Heraeus Platinum-based Anticancer APIs Corporation Information
Table 130. Heraeus Specification and Application
Table 131. Heraeus Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. Heraeus Main Business and Markets Served
Table 133. Heraeus Recent Developments/Updates
Table 134. Heraeus Platinum-based Anticancer APIs Corporation Information
Table 135. Hospira(Pfizer) Specification and Application
Table 136. Hospira(Pfizer) Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. Hospira(Pfizer) Main Business and Markets Served
Table 138. Hospira(Pfizer) Recent Developments/Updates
Table 139. Taj Pharmaceuticals Platinum-based Anticancer APIs Corporation Information
Table 140. Taj Pharmaceuticals Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 141. Taj Pharmaceuticals Main Business and Markets Served
Table 142. Taj Pharmaceuticals Recent Developments/Updates
Table 143. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Corporation Information
Table 144. Umicore Precious Metals Chemistry Specification and Application
Table 145. Umicore Precious Metals Chemistry Platinum-based Anticancer APIs Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 146. Umicore Precious Metals Chemistry Main Business and Markets Served
Table 147. Umicore Precious Metals Chemistry Recent Developments/Updates
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Platinum-based Anticancer APIs Distributors List
Table 151. Platinum-based Anticancer APIs Customers List
Table 152. Platinum-based Anticancer APIs Market Trends
Table 153. Platinum-based Anticancer APIs Market Drivers
Table 154. Platinum-based Anticancer APIs Market Challenges
Table 155. Platinum-based Anticancer APIs Market Restraints
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Platinum-based Anticancer APIs
Figure 2. Global Platinum-based Anticancer APIs Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Platinum-based Anticancer APIs Market Share by Type: 2023 VS 2030
Figure 4. Cisplatin Product Picture
Figure 5. Carboplatin Product Picture
Figure 6. Oxaliplatin Product Picture
Figure 7. Nedaplatin Product Picture
Figure 8. Others Product Picture
Figure 9. Global Platinum-based Anticancer APIs Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 10. Global Platinum-based Anticancer APIs Market Share by Application: 2023 VS 2030
Figure 11. Testicular Cancer
Figure 12. Osteosarcoma
Figure 13. Breast Cancer
Figure 14. Esophageal Cancer
Figure 15. NSCLC
Figure 16. Other
Figure 17. Global Platinum-based Anticancer APIs Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Platinum-based Anticancer APIs Production Value (US$ Million) & (2019-2030)
Figure 19. Global Platinum-based Anticancer APIs Production Capacity (Kiloton) & (2019-2030)
Figure 20. Global Platinum-based Anticancer APIs Production (Kiloton) & (2019-2030)
Figure 21. Global Platinum-based Anticancer APIs Average Price (US$/Ton) & (2019-2030)
Figure 22. Platinum-based Anticancer APIs Report Years Considered
Figure 23. Platinum-based Anticancer APIs Production Share by Manufacturers in 2023
Figure 24. Platinum-based Anticancer APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. The Global 5 and 10 Largest Players: Market Share by Platinum-based Anticancer APIs Revenue in 2023
Figure 26. Global Platinum-based Anticancer APIs Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 27. Global Platinum-based Anticancer APIs Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Platinum-based Anticancer APIs Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 29. Global Platinum-based Anticancer APIs Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Platinum-based Anticancer APIs Production Value (US$ Million) Growth Rate (2019-2030)
Figure 31. Europe Platinum-based Anticancer APIs Production Value (US$ Million) Growth Rate (2019-2030)
Figure 32. China Platinum-based Anticancer APIs Production Value (US$ Million) Growth Rate (2019-2030)
Figure 33. India Platinum-based Anticancer APIs Production Value (US$ Million) Growth Rate (2019-2030)
Figure 34. Global Platinum-based Anticancer APIs Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 35. Global Platinum-based Anticancer APIs Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 36. North America Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 37. North America Platinum-based Anticancer APIs Consumption Market Share by Country (2019-2030)
Figure 38. Canada Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 39. U.S. Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 40. Europe Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 41. Europe Platinum-based Anticancer APIs Consumption Market Share by Country (2019-2030)
Figure 42. Germany Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 43. France Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 44. U.K. Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 45. Italy Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 46. Russia Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 47. Asia Pacific Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 48. Asia Pacific Platinum-based Anticancer APIs Consumption Market Share by Regions (2019-2030)
Figure 49. China Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 50. Japan Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 51. South Korea Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 52. China Taiwan Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 53. Southeast Asia Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 54. India Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 55. Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 56. Latin America, Middle East & Africa Platinum-based Anticancer APIs Consumption Market Share by Country (2019-2030)
Figure 57. Mexico Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 58. Brazil Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 59. Turkey Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 60. GCC Countries Platinum-based Anticancer APIs Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 61. Global Production Market Share of Platinum-based Anticancer APIs by Type (2019-2030)
Figure 62. Global Production Value Market Share of Platinum-based Anticancer APIs by Type (2019-2030)
Figure 63. Global Platinum-based Anticancer APIs Price (US$/Ton) by Type (2019-2030)
Figure 64. Global Production Market Share of Platinum-based Anticancer APIs by Application (2019-2030)
Figure 65. Global Production Value Market Share of Platinum-based Anticancer APIs by Application (2019-2030)
Figure 66. Global Platinum-based Anticancer APIs Price (US$/Ton) by Application (2019-2030)
Figure 67. Platinum-based Anticancer APIs Value Chain
Figure 68. Platinum-based Anticancer APIs Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
